SPEECH-PROCESSING-SOLU
21.6.2016 09:03:13 CEST | Business Wire | Press release
Speech Processing Solutions , the international leader in professional dictation, just launched a new dictation microphone. The improved SpeechMike Premium Touch comes with an innovative touch sensor for optimized and ergonomic navigation, including reduced thumb movement, and an enhanced barcode scanner for quick and easy file association. In addition to these user-friendly updates, the device can scan even more types of bar- and QR codes than its predecessor. The SpeechMike Premium Touch dictation microphone lets healthcare, legal and business professionals dictate their documents, saving them time and resources by allowing them to accomplish their core tasks – benefits that can be directly passed on to their clients.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160621005179/en/
Renowned for its superior microphone quality
The Philips SpeechMike Premium has long been known for its crystal-clear recording quality, and sets the standard for dictation devices worldwide. The free-floating microphone guarantees that almost no background, touch, click, air or structure-borne noise is recorded. “The SpeechMike Premium has established itself as THE benchmark for professional dictation microphones in the industry,” said Dr. Thomas Brauner, CEO of Speech Processing Solutions. “Unrivaled recording quality and noise canceling capabilities, as well as its perfect ergonomics and the antimicrobial surface make it a perfect tool for professional dictation users. These functions are especially helpful for attorneys and medical personnel.”
Focus on content
The new device is equipped with a durable touch sensor. Users can accurately control their mouse cursor using the new SpeechMike Premium Touch. This allows them to easily use and navigate within applications while recording, without having to switch between the mouse and microphone .
Less frequently used functions are placed above or below the sensor, and clearly delineated. Clearly marked distances and different shapes are perfect for operating the device without constantly looking down. Even the Premium Touch’s flip side is optimized for ergonomic and easy use: “Trigger” and “Command” buttons are placed just right to prevent unwanted activation. The key is to focus on content rather than complicated usage instructions. Configurable functions permit a personalized workflow, and an integrated movement sensor that mutes the microphone when not in use adds a finishing touch. “The new features guarantee smooth and convenient operation, even when recording over longer periods of time every day. The Premium Touch can also read more barcodes than its predecessor, allowing end users to quickly categorize and associate client and patient data. The results are enhanced security and potential cost savings,” said Brauner.
Speech to text made easy
Philips SpeechMike Premium Touch makes going from recording your voice to a written document a simple process. The dictation microphone is easy to integrate into users’ IT infrastructures, and works in harmony with existing software, both in large hospitals or small businesses. Thanks to the excellent recording quality, Philips SpeechMike Premium Touch is perfectly suited for transcription, whether by an assistant, speech recognition software, or Philips dictation workflow solutions such as SpeechLive and SpeechExec.
Philips SpeechLive dictation solution
Philips workflow software creates a smooth and safe work cycle between authors and transcriptionists. “Philips SpeechLive is a perfect solution for people like myself, who are on the go a lot. It guarantees a reliable and safe transmission of dictations, regardless of what time it is” explained Dr. Peter Klein, partner at the international law firm PFKA, in Austria adding that: “The offered transcription service is another advantage, particularly in foreign languages such as French, as it virtually increases our office’s capacity.”
For more information on the Philips SpeechMike Premium Touch (SMP3700/3800 series) visit: www.philips.com/dictation
Philips is now offering a free 30-day SpeechLive trial including 10 free transcription minutes at: www.speechlive.com
About Speech Processing Solutions
Speech Processing Solutions is the global number one in professional dictation. Founded in Austria in 1954 as part of Philips, the company has been the driving force in speech-to-text innovations for over 60 years. Always striving for excellence and putting emphasis on outstanding quality, the company has designed groundbreaking products, such as the portable Philips Pocket Memo voice recorder , the Philips SpeechMike Premium dictation microphone and the Philips SpeechExec dictation recorder app for smartphones. The latest innovation, Philips SpeechLive , makes dictation quicker and more convenient than ever before, by bringing secure dictation workflow to the cloud and enabling seamless speech-to-text with the new speech recognition service. With solutions perfectly tailored to individual industry needs, Speech Processing Solutions has helped millions of satisfied customers around the globe save time and resources, allowing them to work as efficiently as possible.
Connect with Speech Processing Solutions on:
Facebook: http://www.facebook.com/philipsvoicetracer
Twitter @speech_com: http://www.twitter.com/speech_com
YouTube: http://www.youtube.com/philipsdictation
LinkedIn: http://www.linkedin.com/company/speech-processing-solutions
View source version on businesswire.com: http://www.businesswire.com/news/home/20160621005179/en/
Contact:
Speech Processing Solutions
Lea Pachta
lea.pachta@speech.com
Tel:
+43 1 60529-1744
www.philips.com/dictation
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom